Abstract

We have demonstrated that epoxyeicosatrienoic acids (EETs), the cytochrome P450 epoxygenase metabolites of arachidonic acid, inhibit both intrinsic and extrinsic pathways of apoptosis of human endothelial cells, through activation of phosphatidyl inositol 3‐kinase (PI3K). EETs are also potent sarcolemmal and mitochondrial ATP‐sensitive K+ (KATP) channel activators. In this study, we examined the effects of EETs on hypoxia/reoxygenation (HR)‐induced apoptosis (as determined by measuring increase in caspase 3 activity) in mouse pulmonary arteries maintained ex vivo, by organ culture. Mouse pulmonary arteries subjected to HR for 8/16 h demonstrated increased apoptosis. This was inhibited by pretreatment with either 14,15‐EET (300 nM), the non‐specific KATP channel opener pinacidil (100 microM) or the mitochondrial KATP channel opener, diazoxide (100 microM). Pretreatment with the PI3K inhibitor, wortmannin abolished the protective effect of EET, pinacidil or diazoxide. There was no cumulative effect of wortmannin and glibenclamide when applied together, on the apoptotic indices during HR. Thus, cross‐talk between PI3K and KATP channels, two targets of signaling by EET, mediate protection of the pulmonary vasculature. Funding: NIH/NHLBI 69996 (MMM), 68627 (ERJ), 49294 (ERJ), GM 31278 (JRF).

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.